One in Five Cancers in the United States Is Classified as Rare

This article originally appeared here.
Share this content:
A cancer type diagnosed in less than six cases per 100,000 people, per year, is considered rare.
A cancer type diagnosed in less than six cases per 100,000 people, per year, is considered rare.

(HealthDay News) -- Rare cancers account for one in five cancers diagnosed in the United States, presenting special challenges to doctors and patients, according to research published online May 19 in CA: A Cancer Journal for Clinicians.

A cancer is considered rare when it's one that's diagnosed in fewer than six cases per 100,000 people a year. Overall, the analysis of national cancer data showed that 20 percent of all cancers are rare cancers. Rare cancers make up 24 percent of cancers diagnosed in Hispanics and 22 percent of cancers in Asian/Pacific Islanders. The rates for blacks and whites are 20 and 19 percent, respectively. The researchers also found that 71 percent of cancers in children and teens are rare, compared with less than 20 percent of cancers diagnosed in adults 65 and older.

Rare cancers tend to be diagnosed at a later stage, and the five-year survival rate for adults with unusual cancers is lower than for other cancers. In men, for example, the rates are 55 versus 75 percent. However, 82 percent of children and teens with rare cancers survive five years, compared to 46 percent of older adults (aged 65 to 79) with rare cancers, the investigators found.

"Continued efforts are needed to develop interventions for prevention, early detection, and treatment to reduce the burden of rare cancers," the authors write. "Such discoveries can often advance knowledge for all cancers."

Full Text

You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs